Abstract
Novel series of chalcones were synthesized and were evaluated as possible anti-inflammatory agents targeting the cyclooxygenase-1 and 2 (COX-1 and 2), β-glucuronidase, trypsin, and TNF-α. Amongst the tested chalcones the compound 4k was found to be most effective inhibitor of TNF-α exhibiting 85% inhibition activity (IC50 = 0.1 μM). The compounds 4a, 4f, 4l, and 4m were found to inhibit the COX-1 activity in as a range of 79.95–68.47% and COX-2 inhibition ranging 84.45–74.77%. The compounds 4l (81.71%) and 4f (72.10%) were found to be excellent inhibitors of trypsin and β-glucuronidase, respectively.
Similar content being viewed by others
References
Ahluwalia VK (2005) Intermediates for organic synthesis. I. K. International Publisher, New Delhi
Bandgar BP, Patil SA, Gacche RN, Korbad BL, Hote BS, Kinkar SN, Jalde SS (2010) Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents. Bioorg Med Chem Lett 20:730–733
Bartolome B, Nunez V, Monagas M, Gomez-Cordoves C (2004) In vitro antioxidant activity of red grape skins. Eur Food Res Technol 218:173–177
Bilfinger TV, George BS (2002) The role of protease inhibition with emphasis on the effects of inflammation and vascular immune phenomena. Curr Pharm Design 8:125–133
Bois F, Beney C, Boumendijel A, Mariotte AM, Conseil G, DiPietro A (1998) Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance. J Med Chem 41:4161–4164
Cechinel-Filho VF, Vaz ZR, Zunino L, Calixto JB, Yunes RA (1996) Synthesis of xanthoxyline derivatives with antinociceptive and antioedematogenic activities. Eur J Med Chem 31:833–839
Dhar DN (1981) The chemistry of chalcones and related compounds. Wiley, New York
Di Carlo G, Mascolo N, Izzo AA, Capasso F (1999) Flavonoids: old and new aspects of a class natural therapeutic drugs. Life Sci 65:337–353
Ducki S, Forrest R, Hadfield JA, Kendall A, Lawrence NJ, McGown AT, Rennison D (1998) Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg Med Chem Lett 8:1051–1056
Furman C, Lebeau J, Fruchart J-C, Bernier J-L, Duriez P, Cotelle N, Teissier E (2001) Di-tert-butylhydroxylated flavonoids protect endothelial cells against oxidized LDL-induced cytotoxicity. J Biochem Mol Toxicol 15:270–278
Gacche RN, Dhole NA (2006) Antioxidant and possible anti-inflammatory potential of selected medicinal plants prescribed in Indian traditional system of medicine. Pharm Biol 44:389–395
Gacche R, Khsirsagar M, Kamble S, Bandgar B, Dhole N, Shisode K, Chaudhar A (2008) Antioxidant and anti-inflammatory related activities of selected synthetic chalcones: structure–activity relationship studies using computational tools. Chem Pharm Bull 56:897–901
Geronikaki AA, Gavalas AM (2006) Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb Chem High Throughput Screen 9:425–442
Gutteridge JM (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41:1819–1828
Herencia F, Ferraindiz ML, Ubeda A, Dominguez JN, Charris JE, Lobo GM, Alcaraz MJ (1998) Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg Med Chem Lett 8:1169–1174
Herencia F, Ferrándiz ML, Ubeda A, Guillén I, Dominguez JN, Charris JE, Lobo GM, Alcaraz MJ (2001) 4-dimethylamino-3,4-dimethoxy chalcones down regulates inos expression and exerts anti-inflammatory effects. Free Radic Biol Med 30:43–50
Hsieh H-K, Lee T-H, Wang J-P, Wang J-J, Lin C-N (1998) Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm Res 15:39–46
Hsieh H-K, Tsao L-T, Wang J-P (2000) Synthesis and anti-inflammatory effect of chalcones. J Pharm Pharmacol 52:163–171
Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866–12872
Linn Y-M, Zhou Y, Flavin MT, Zhou L-M, Nie W, Chen F-C (2002) Chalcones and flavonoids as anti-tuberculosis agents. Bioorg Med Chem 10:2795–2802
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. Biol Chem 193:265–275
Marnett LJ (2000) Cyclooxygenase mechanisms. Curr Opin Chem Biol 4:545–552
Miyachi H, Azuma A, Hioki E, Iwasaki S, Kobayashi Y, Hashimoto Y (1996) Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production. Biochem Biophys Res Commun 224:426–430
Miyachi H, Azuma A, Ogasawara A, Uchimura E, Watanabe N, Kobayashi Y, Kato F, Kato M, Hashimoto Y (1997) Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance. J Med Chem 40:2858–2865
Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416–421
Nicolaides DN, Fylaktakidou CF, Litinas KE, Hadjipavlou-Litina D (1998) Synthesis and biological evaluation of several coumarin-4-carboxamidoxime and 3-(coumarin-4-yl)-1,2,4-oxadiazole derivatives. Eur J Med Chem 33:715–724
Pairet M, Engelhardt G (1996) Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 10:1–15
Sasaki K, Matsumato I, Beppu M (1991) Affinity Chromatography, Tokyo Kagaku Dojin: Tokyo
Satyanarayana M, Tiwari P, Tripathi BK, Srivastava AK, Pratab R (2004) Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines. Bioorg Med Chem 12:883–889
Shibata Y, Sasaki K, Hashimoto Y, Iwasaki S (1994) Tumor necrosis factor-α production enhancers with a phenylphthalimide skeleton. Biochem Biophys Res Commun 205:1992–1997
Tandon M, Tandon P, Barthwal JP, Bhalla TN, Bhargava KP (1982) Anti-inflammatory and anti-proteolytic activities of newer indolyl-isoquinilines. Drug Res 32:1233–1235
Vane JR, Botting RM (1996) Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol 102:9–21
Wilson KP, McCaffrey PG, Hsiao K, Pazhanisamy S, Galullo V, Bemis GW, Fitzgibbon MJ, Caron PR, Murcko MA, Su MSS (1997) The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem Biol 4:423–431
Xia Y, Yang ZY, Xia P, Bastow KI, Nakanishi Y, Lee K-H (2000) Antitumor agents. Part 202: novel 2′-amino chalcones: design, synthesis and biological evaluation. Bioorg Med Chem Lett 10:699–701
Acknowledgment
Authors are thankful to the Council of Scientific and Industrial Research (CSIR), New Delhi for the award of SRF to Mr. B.S.Hote, as well as to Mr. Mahesh Nambiar and Mrs. Asha Almeida, Piramal life Sciences Ltd., Mumbai for TNF-screening of the compounds.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bandgar, B.P., Hote, B.S., Dhole, N.A. et al. Synthesis and biological evaluation of novel series of chalcone derivatives as inhibitors of cyclooxygenase and LPS-induced TNF-α with potent antioxidant properties. Med Chem Res 21, 2292–2299 (2012). https://doi.org/10.1007/s00044-011-9746-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-011-9746-6